Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Keyword
-
- Anticonvulsant (1)
- Anticonvulsants (1)
- Apparatus (1)
- Aryl substituted (1)
- Burns (1)
-
- Compositions (1)
- Diphenylaziridines (1)
- Drugs (1)
- Equine pharmacology (1)
- Function (1)
- Infusion (1)
- Intubation (1)
- Method (1)
- Multiple (1)
- Pesticidal (1)
- Pesticide (1)
- The Best in Medicine: where to get the finest health care for you and your family (1)
- Topical (1)
- Treatment (1)
- Triazole (1)
- Trizoles (1)
- Veterinary drugs (1)
- Wounds (1)
Articles 1 - 7 of 7
Full-Text Articles in Medicine and Health Sciences
Aryl Substituted 1h-4,5-Dihydro-1,2,3-Triazoles As Anticonvulsants, Pankaja K. Kadaba
Aryl Substituted 1h-4,5-Dihydro-1,2,3-Triazoles As Anticonvulsants, Pankaja K. Kadaba
Pharmaceutical Sciences Faculty Patents
Anticonvulsant compositions comprise as the active ingredient a compound . . .
To see the remainder of this abstract, please download this patent.
Multiple Function Intubation Apparatus And Method, Jane A. Norton, Diana L. Twyman, A. Byron Young, Robert Rapp
Multiple Function Intubation Apparatus And Method, Jane A. Norton, Diana L. Twyman, A. Byron Young, Robert Rapp
Surgery Faculty Patents
An apparatus and its method of use are provided allowing lavage, sump and enteral feeding operations with only one intubation. The apparatus includes a first tube having two distinct passageways. One of these passageways completely contains a second, feeding tube during intubation. Once the first tube is in place in the patient, the second tube is extended from the first tube so as to enter the stomach. The extension of the second tube opens ports in the first passageway of the first tube, thereby allowing sump or lavage treatment with the second passageway of the first tube serving as an …
1,2,3,-Triazole Anticonvulsant Drugs, Pankaja K. Kadaba
1,2,3,-Triazole Anticonvulsant Drugs, Pankaja K. Kadaba
Pharmaceutical Sciences Faculty Patents
Anticonvulsant compositions comprise as the active ingredient a compound . . .
To see the remainder of this abstract, please download this patent.
[Review Of] The Best In Medicine: Where To Get The Finest Health Care For You And Your Family, Robert A. Aken
[Review Of] The Best In Medicine: Where To Get The Finest Health Care For You And Your Family, Robert A. Aken
Library Faculty and Staff Publications
No abstract provided.
Composition For Topical And Infusion Treatment Of Wounds And Burns, Thomas W. Swerczek
Composition For Topical And Infusion Treatment Of Wounds And Burns, Thomas W. Swerczek
Veterinary Science Faculty Patents
A composition is provided for the treatment of contagious equine metritis, a contagious venereal disease of horses. The composition appears to function as a biological inhibitor and has antibacterial and antifungal activity when applied to the normal flora and secretions of the epidermis and mucous membranes. Also, the composition has antipruritic and anti-inflammatory activity. The composition is efficacious in the treatment of lesions produced by bacteria, fungi, allergies, viruses, trauma, and burns to the epidermis, dermis, muscles and mucous membranes of the surface or in body cavities of animals and man.
The composition preferably comprises an aqueous solution of dextrose, …
Pesticidal Diphenylaziridines, Pankaja K. Kadaba, Douglas Lee Dahlman
Pesticidal Diphenylaziridines, Pankaja K. Kadaba, Douglas Lee Dahlman
Pharmaceutical Sciences Faculty Patents
Substituted 1,2-diphenylaziridines, particularly those which are substituted by halogen, are useful as pesticidal compositions. . . .
To read the remainder of this abstract, please download this patent.
Phenylbutazone In The Horse: A Review, Thomas Tobin, S. Chay, S. Kamerling, W. E. Woods, T. J. Weckman, J. W. Blake, P. Lees
Phenylbutazone In The Horse: A Review, Thomas Tobin, S. Chay, S. Kamerling, W. E. Woods, T. J. Weckman, J. W. Blake, P. Lees
Maxwell H. Gluck Equine Research Center Faculty Publications
Phenylbutazone is an acidic, lipophilic, nonsteroidal anti-inflammatory drug (NSAID). It is extensively metabolized in the horse. The metabolites so far identified, oxyphenbutazone, y-hydroxyphenylbutazone and y-hydroxyoxyphenbutazone. account for some 25-30% of administered dose over 24 h. The plasma half-life of phenylbutazone and termination of its pharmacological action are determined primarily by its rate of hepatic metabolism. Phenylbutazone acts by inhibiting the cyclooxygenase enzyme system, which is responsible for synthesis of prostanoids such as PGE?. It appears to act on prostaglalidin-H synthase and prostacyclin synthase, after conversion by prostaglandin-H synthase to reactive intermediates. It markedly reduces prostanoid-dependent swelling, edema, erythema, and hypersensitivity …